Literature DB >> 23532894

Improved survival with HPV among African Americans with oropharyngeal cancer.

Maria J Worsham1, Josena K Stephen, Kang Mei Chen, Meredith Mahan, Vanessa Schweitzer, Shaleta Havard, George Divine.   

Abstract

PURPOSE: A major limitation of studies reporting a lower prevalence rate of human papilloma virus (HPV) in African American patients with oropharyngeal squamous cell cancer (OPSCC) than Caucasian Americans, with corresponding worse outcomes, was adequate representation of HPV-positive African American patients. This study examined survival outcomes in HPV-positive and HPV-negative African Americans with OPSCC. EXPERIMENTAL
DESIGN: The study cohort of 121 patients with primary OPSCC had 42% African Americans. Variables of interest included age, race, gender, HPV status, stage, marital status, smoking, treatment, and date of diagnosis.
RESULTS: Caucasian Americans are more likely to be HPV positive (OR = 3.28; P = 0.035), as are younger age (age < 50 OR = 7.14; P = 0.023 compared with age > 65) or being married (OR = 3.44; P = 0.016). HPV positivity and being unmarried were associated with being late stage (OR = 3.10; P = 0.047 and OR = 3.23; P = 0.038, respectively). HPV-negative patients had 2.7 times the risk of death as HPV-positive patients (P = 0.004). Overall, the HPV-race groups differed (log-rank P < 0.001), with significantly worse survival for HPV-negative African Americans versus (i) HPV-positive African Americans (HR = 3.44; P = 0.0012); (ii) HPV-positive Caucasian Americans (HR = 3.11; P = < 0.049); and (iii) HPV-negative Caucasian Americans (HR = 2.21; P = 0.049).
CONCLUSIONS: HPV has a substantial impact on overall survival in African American patients with OPSCC. Among African American patients with OPSCC, HPV-positive patients had better survival than HPV negative. HPV-negative African Americans also did worse than both HPV-positive Caucasian Americans and HPV-negative Caucasian Americans. This study adds to the mounting evidence of HPV as a racially linked sexual behavior life style risk factor impacting survival outcomes for both African American and Caucasian American patients with OPSCC. ©2013 AACR.

Entities:  

Mesh:

Year:  2013        PMID: 23532894      PMCID: PMC3644015          DOI: 10.1158/1078-0432.CCR-12-3003

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  34 in total

1.  A causal role for human papillomavirus in head and neck cancer.

Authors:  M L Gillison; D R Lowy
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

Review 2.  Human papillomavirus and head and neck cancer: a systematic review and meta-analysis.

Authors:  C G L Hobbs; J A C Sterne; M Bailey; R S Heyderman; M A Birchall; S J Thomas
Journal:  Clin Otolaryngol       Date:  2006-08       Impact factor: 2.597

3.  Racial disparities in patients with head and neck squamous cell carcinoma.

Authors:  Christine G Gourin; Robert H Podolsky
Journal:  Laryngoscope       Date:  2006-07       Impact factor: 3.325

4.  Nicotine affects the signaling of the death pathway, reducing the response of head and neck cancer cell lines to DNA damaging agents.

Authors:  N Onoda; A Nehmi; D Weiner; S Mujumdar; R Christen; G Los
Journal:  Head Neck       Date:  2001-10       Impact factor: 3.147

5.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

6.  Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States--possible role for human papillomavirus in survival disparities.

Authors:  Travis P Schrank; Yimei Han; Heidi Weiss; Vicente A Resto
Journal:  Head Neck       Date:  2011-01       Impact factor: 3.147

Review 7.  The role of human papillomavirus in head and neck cancer.

Authors:  Christel Braemer Lajer; Christian von Buchwald
Journal:  APMIS       Date:  2010-06       Impact factor: 3.205

8.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

9.  Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma.

Authors:  Kangmei Chen; Raja Sawhney; Mumtaz Khan; Michael S Benninger; Zizheng Hou; Seema Sethi; Josena K Stephen; Maria J Worsham
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-11

10.  Oral sexual behaviors associated with prevalent oral human papillomavirus infection.

Authors:  Gypsyamber D'Souza; Yuri Agrawal; Jane Halpern; Sacared Bodison; Maura L Gillison
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

View more
  23 in total

1.  Racial disparities in Human Papillomavirus (HPV) associated head and neck cancer.

Authors:  Jose Jiron; Seema Sethi; Rouba Ali-Fehmi; Silvia Franceschi; Linda Struijk; Leen-Jan van Doorn; Wim Quint; Ikuko Kato
Journal:  Am J Otolaryngol       Date:  2013-09-28       Impact factor: 1.808

2.  Outcomes of HPV-Associated Squamous Cell Carcinoma of the Head and Neck: Impact of Race and Socioeconomic Status.

Authors:  Luke R G Pike; Trevor J Royce; Amandeep R Mahal; Daniel W Kim; William L Hwang; Brandon A Mahal; Nina N Sanford
Journal:  J Natl Compr Canc Netw       Date:  2020-02       Impact factor: 11.908

3.  Human papillomavirus status and gene expression profiles of oropharyngeal and oral cancers from European American and African American patients.

Authors:  Swati Tomar; Christian A Graves; Diego Altomare; Sangeeta Kowli; Susannah Kassler; Natalie Sutkowski; M Boyd Gillespie; Kim E Creek; Lucia Pirisi
Journal:  Head Neck       Date:  2015-06-15       Impact factor: 3.147

4.  The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.

Authors:  Carole Fakhry; William H Westra; Steven J Wang; Annemieke van Zante; Yuehan Zhang; Eleni Rettig; Linda X Yin; William R Ryan; Patrick K Ha; Alicia Wentz; Wayne Koch; Jeremy D Richmon; David W Eisele; Gypsyamber D'Souza
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

5.  The complex relation between race, sex, and human papillomavirus status in head and neck cancer.

Authors:  Jose P Zevallos; Angela L Mazul
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

6.  High prevalence of discordant human papillomavirus and p16 oropharyngeal squamous cell carcinomas in an African American cohort.

Authors:  Jeffrey C Liu; Shobha Parajuli; Elizabeth Blackman; Denise Gibbs; Ashley Ellis; Anna Hull; J Robert Beck; Veda Giri; Patrick Iherjirka; Jasvir S Khurana; Camille R Ragin
Journal:  Head Neck       Date:  2015-07-18       Impact factor: 3.147

7.  Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center.

Authors:  Dan P Zandberg; Sandy Liu; Olga Goloubeva; Robert Ord; Scott E Strome; Mohan Suntharalingam; Rodney Taylor; Robert E Morales; Jeffrey S Wolf; Ann Zimrin; Joshua E Lubek; Lisa M Schumaker; Kevin J Cullen
Journal:  Head Neck       Date:  2015-06-30       Impact factor: 3.147

8.  Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation.

Authors:  Alexis J Platek; Vijayvel Jayaprakash; Mihai Merzianu; Mary E Platek; David M Cohan; Wesley L Hicks; Sathiya P Marimuthu; Timothy B Winslow; Vishal Gupta; Hassan Arshad; Moni A Kuriakose; Shiva Dibaj; James R Marshall; Mary E Reid; Graham W Warren; Anurag K Singh
Journal:  Laryngoscope       Date:  2016-06-27       Impact factor: 3.325

Review 9.  [Is (chemo)radiotherapy really the future standard in the treatment of oropharyngeal carcinoma?].

Authors:  R Knecht; L Bussmann; N Möckelmann; B B Lörincz
Journal:  HNO       Date:  2016-04       Impact factor: 1.284

10.  Epigenetic modulation of signal transduction pathways in HPV-associated HNSCC.

Authors:  Maria J Worsham; Kang Mei Chen; Tamer Ghanem; Josena K Stephen; George Divine
Journal:  Otolaryngol Head Neck Surg       Date:  2013-06-04       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.